Format

Send to

Choose Destination
See comment in PubMed Commons below
ScientificWorldJournal. 2012;2012:350826. doi: 10.1100/2012/350826. Epub 2012 Jan 4.

Rottlerin and cancer: novel evidence and mechanisms.

Author information

1
Department of Physiology, University of Siena, Aldo Moro Street, 53100 Siena, Italy. maioli@unisi.it

Abstract

Because cancers are caused by deregulation of hundreds of genes, an ideal anticancer agent should target multiple gene products or signaling pathways simultaneously. Recently, extensive research has addressed the chemotherapeutic potential of plant-derived compounds. Among the ever-increasing list of naturally occurring anticancer agents, Rottlerin appears to have great potentiality for being used in chemotherapy because it affects several cell machineries involved in survival, apoptosis, autophagy, and invasion. The underlying mechanisms that have been described are diverse, and the final, cell-specific, Rottlerin outcome appears to result from a combination of signaling pathways at multiple levels. This paper seeks to summarize the multifocal signal modulatory properties of Rottlerin, which merit to be further exploited for successful prevention and treatment of cancer.

PMID:
22272173
PMCID:
PMC3259573
DOI:
10.1100/2012/350826
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center